Building upon the functional attributes of PARP and the underlying principles of PARPi-induced tumor cell death, combination strategies involving DNA damage inducers, AKT inhibitors, angiogenesis inhibitors, and other agents are being investigated as promising approaches for the treatment of GC (Figure 4). Here, AKT1 is linked to neoplasm.